Disease modifying anti-rheumatic drugs/Related Articles

From Citizendium
< Disease modifying anti-rheumatic drugs
Revision as of 18:38, 18 September 2010 by imported>Howard C. Berkowitz
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Disease modifying anti-rheumatic drugs: Drugs that directly affect the underlying autoimmune processes in rheumatological disease, rather than act simply as analgesics or nonspecific antiinflammatories; they include gold compounds (e.g., aurothioglucose), antimalarials, penicillamine, and monoclonal antibodies against tumor necrosis factor-alpha and other immunochemicals [e]

This article contains just a definition and optionally other subpages (such as a list of related articles), but no metadata. Create the metadata page if you want to expand this into a full article.

Parent topics

  • Rheumatology [r]: Medical specialty that deals with the study, diagnosis, and treatment of connective tissue diseases; a subspecialty of internal medicine [e]
  • Autoimmune disease [r]: Disorders that are characterized by the production of antibodies that react with host tissues or immune effector cells that are autoreactive to endogenous peptides. [e]

Subtopics

Drugs

Diseases

Other related topics